Skip to Content
COVID-19 Response and Update

2002: Amneal Founded - 2005: Oral Solids - 2008: Oral Liquids - 2011: Topicals - 2015: Inserts/Implants, Inhalation - 2016: Injectables - 2017: Nasal Sprays - 2019: Transdermal Patches - 2020: Ophthalmics - 2022: LYVISPAH™ - 2022: DHE Autoinjector - 2022: Biosimilars - 2023: International Expansion, IPX-203 - 2023-2024: K-127 - 2024-2025: K-114